Specifically, IL-1β can promote AML blasts proliferation and survival, through the generation of a pro-inflammatory BM microenvironment, enhancing the production of other pro-leukemic chemokines and disrupting the anti-tumor immune response. This evidence concerns the gene IL1B and neoplasm.